Patents by Inventor Chi-Fang Wu

Chi-Fang Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HISTIDYL-TRNA SYNTHETASE-FC CONJUGATES
    Publication number: 20140349369
    Abstract: The present invention provides histidyl-tRNA synthetase and Fc region conjugate polypeptides (HRS-Fc conjugates), such as HRS-Fc fusion polypeptides, compositions comprising the same, and methods of using such conjugates and compositions for treating or diagnosing a variety of conditions. The HRS-Fc conjugates of the invention have improved controlled release properties, stability, half-life, and other pharmacokinetic and biological properties relative to corresponding, unmodified HRS polypeptides.
    Type: Application
    Filed: March 14, 2014
    Publication date: November 27, 2014
    Inventors: Ying Buechler, Kyle Chiang, Minh-Ha Do, Darin Lee, Kristi Piehl, Marc Thomas, Jeffry D. Watkins, Chi-Fang Wu, John D. Mendlein
  • ASPARTYL-TRNA SYNTHETASE-FC CONJUGATES
    Publication number: 20140335087
    Abstract: The present invention provides aspartyl-tRNA synthetase and Fc region conjugate polypeptides (DRS-Fc conjugates), such as DRS-Fc fusion proteins, compositions comprising the same, and methods of using such conjugates and compositions for treating or diagnosing a variety of conditions. The DRS-Fc conjugates of the invention have improved controlled release properties, stability, half-life, and other pharmacokinetic and biological properties relative to corresponding, unmodified DRS polypeptides.
    Type: Application
    Filed: December 27, 2012
    Publication date: November 13, 2014
    Inventors: Ying Ji Buechler, Chi-Fang Wu, Ryan Andrew Adams, Jeffrey D. Watkins, John D. Mendlein
  • ASPARTYL-TRNA SYNTHETASES
    Publication number: 20140302075
    Abstract: The present invention provides aspartyl-tRNA synthetase derived proteins (DRS polypeptides) with altered cysteine content, compositions comprising the same, and methods of using such polypeptides and compositions for treating or diagnosing a variety of conditions. The DRS polypeptides of the invention have immunomodulatory properties, and exhibit improved activity and stability.
    Type: Application
    Filed: December 6, 2012
    Publication date: October 9, 2014
    Inventors: Ying Ji Buechler, Chi-Fang Wu, Ryan Andrew Adams, Kristi Helen Piehl, Jeffrey Greve, John D. Mendlein
  • PEGYLATED TYROSYL-TRNA SYNTHETASE POLYPEPTIDES
    Publication number: 20140255378
    Abstract: The present invention provides PEGylated tyrosyl-tRNA synthetase (YRS) polypeptides, compositions comprising the same, and methods of using such polypeptides and compositions for treating or diagnosing a variety of conditions. The PEGylated YRS polypeptides of the invention have improved controlled release properties, stability, half-life, and other pharmacokinetic properties compared to non-PEGylated YRS polypeptides.
    Type: Application
    Filed: August 8, 2012
    Publication date: September 11, 2014
    Applicant: aTyr Pharma, Inc
    Inventors: Jeffrey D. Watkins, Ying Ji Buechler, Chi-Fang Wu, Minh-Ha Do, Alain P. Vasserot, John D. Mendlein
  • Baby walker with improved safety
    Publication number: 20030184036
    Abstract: A baby walker comprises a lower chassis having a plurality of casters mounted to an underside thereof, an upper chassis mounted above the lower chassis and including a seat, and a supporting device mounted between the upper chassis and the lower chassis for supporting the upper chassis. At least one illuminating element is mounted to at least one of the upper chassis and the lower chassis. A power source supplies electricity to the illuminating element, and a switch controls on/off of the illuminating element.
    Type: Application
    Filed: March 29, 2002
    Publication date: October 2, 2003
    Inventor: Chi-Fang Wu